ArticleMedComm2021
Clinical benefit of neoadjuvant anti-PD-1/PD-L1 utilization among different tumors.
Zhiyang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled ittrialcites it
ArticleMedComm2021
Zhiyang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.